Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chairman and CEO of RESMED INC. Currently has a direct ownership of 466,223 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Dec 08, 2025, when has been sold 4,991 shares (ResMed Common Stock) at a price of $251.41 per share, resulting in proceeds of $1,254,787. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 466K

0.34% 3M change

2.36% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 08 2025	SELL Open market or private sale	$1,254,787 $251.41 p/Share	4,991 Reduced 1.06%	466,223 ResMed Common Stock
Dec 08 2025	BUY Exercise of conversion of derivative security	$730,382 $146.34 p/Share	4,991 Added 1.05%	471,214 ResMed Common Stock
Nov 20 2025	SELL Payment of exercise price or tax liability	-	7,297 Reduced 1.54%	466,223 ResMed Common Stock
Nov 20 2025	BUY Grant, award, or other acquisition	-	13,551 Added 2.78%	473,520 ResMed Common Stock
Nov 11 2025	SELL Payment of exercise price or tax liability	$1,974,539 $250.1 p/Share	7,895 Reduced 1.69%	459,969 ResMed Common Stock
Nov 07 2025	SELL Open market or private sale	$2,000,747 $249.75 p/Share	8,011 Reduced 1.68%	467,866 ResMed Common Stock
Nov 07 2025	BUY Exercise of conversion of derivative security	$814,238 $101.64 p/Share	8,011 Added 1.66%	475,877 ResMed Common Stock

Oct 07 2025	SELL Open market or private sale	$2,265,345 $282.85 p/Share	8,009 Reduced 1.68%	467,792 ResMed Common Stock
Oct 07 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.66%	475,801 ResMed Common Stock
Sep 08 2025	SELL Open market or private sale	$2,227,623 $278.14 p/Share	8,009 Reduced 1.68%	467,792 ResMed Common Stock
Sep 08 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.66%	475,801 ResMed Common Stock
Aug 15 2025	BUY Grant, award, or other acquisition	-	12,289 Added 2.56%	467,792 ResMed Common Stock
Aug 07 2025	SELL Open market or private sale	$2,238,355 $279.48 p/Share	8,009 Reduced 1.73%	455,503 ResMed Common Stock
Aug 07 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.7%	463,512 ResMed Common Stock
Jul 07 2025	SELL Open market or private sale	$2,056,070 $256.72 p/Share	8,009 Reduced 1.73%	455,503 ResMed Common Stock
Jul 07 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.7%	463,512 ResMed Common Stock
Jun 09 2025	SELL Open market or private sale	$2,011,940 $251.21 p/Share	8,009 Reduced 1.73%	455,503 ResMed Common Stock
Jun 09 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.7%	463,512 ResMed Common Stock
May 07 2025	SELL Open market or private sale	$1,948,029 $243.23 p/Share	8,009 Reduced 1.73%	455,503 ResMed Common Stock
May 07 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.7%	463,512 ResMed Common Stock
Apr 07 2025	SELL Open market or private sale	$1,680,688 $209.85 p/Share	8,009 Reduced 1.73%	455,472 ResMed Common Stock
Apr 07 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.7%	463,482 ResMed Common Stock
Mar 07 2025	SELL Open market or private sale	$1,835,662 $229.2 p/Share	8,009 Reduced 1.73%	455,472 ResMed Common Stock
Mar 07 2025	BUY Exercise of conversion of derivative security	$814,034 $101.64 p/Share	8,009 Added 1.7%	463,481 ResMed Common Stock
Feb 07 2025	SELL Open market or private sale	$1,896,290 $236.77 p/Share	8,009 Reduced 1.73%	455,472 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

MJF